| Issue |
Section |
Title |
File |
| Vol 160, No 6 (2016) |
Article |
Regulatory Proteins of Epithelial-Mesenchymal Transition and Some Components of VEGF Signaling Pathway in Breast Cancer |
|
| Vol 160, No 6 (2016) |
Article |
Insulin-Like Growth Factors (IGF) and IGF-Binding Proteins (IGFBP) in the Serum of Patients with Ovarian Tumors |
|
| Vol 163, No 2 (2017) |
Oncology |
Association between the Prevalence of Somatic Mutations in PIK3CA Gene in Tumors and Clinical and Morphological Characteristics of Breast Cancer Patients |
|
| Vol 163, No 4 (2017) |
Article |
Receptor Activator of Nuclear Transcription Factor NF-κB (RANK), Its Ligand RANKL, and Natural Inhibitor of RANKL Osteoprotegerin (OPG) in the Blood Serum of Patients with Primary Bone Tumors |
|
| Vol 165, No 1 (2018) |
Oncology |
Matrix Metalloproteinases and Their Tissue Inhibitors in Blood Serum of Patients with Endometrial Cancer: Clinical and Morphological Correlations |
|
| Vol 166, No 3 (2019) |
Article |
Soluble Ligand of the Immune Checkpoint Receptor (sPD-L1) in Blood Serum of Patients with Renal Cell Carcinoma |
|
| Vol 166, No 3 (2019) |
Oncology |
Clinical Significance of Matrix Metalloproteinases in Blood Plasma of Patients with Gastric Cancer |
|
| Vol 167, No 1 (2019) |
Article |
Comparative Analysis of Blood Plasma Proteome in Patients with Renal Cell Carcinoma |
|
| Vol 167, No 3 (2019) |
Oncology |
Kidney Injury Molecule-1 (KIM-1) in Blood Plasma of Patients with Clear-Cell Carcinoma |
|
